CAI logo

CAI Caris Life Sciences, Inc.

NASDAQ Global Select · Biotechnology · Healthcare

$17.58
-0.96 (-5.18%)

Caris Life Sciences, Inc. operates as a leading "TechBio" firm, harnessing artificial intelligence to deliver comprehensive molecular profiling services to clients both in the United States and internationally. The company is dedicated to transforming medical care by innovating and bringing to market advanced solutions that leverage molecular data and sophisticated machine learning algorithms. Its…

Market Cap: $5.04Bwww.carislifesciences.com

Price

No data yet.

Social Signal Score

59
5d
—
30d
61
9 mentions
—
60d
58
13 mentions
—
90d
58
21 mentions
—
rss: 6 · news: 13 · 4chan: 2

Analyst Ratings

9 analysts
Buyconsensus
Strong Buy 0Buy 7Hold 2Sell 0Strong Sell 0
Avg price target$34+93.4%
Low $26Median $38High $38
Current Consensus

Revenue

$275.36M+221.32%
$80.68M$151.41M$222.15M$292.89M
Jun 2021Sep 2026

Analyst Estimates

FY2025
$-1.06
$-1.11–$-1.00
2 analysts
FY2026
$0.11
$0.10–$0.12
8 analysts
FY2027
$0.28+147% YoY
$0.25–$0.29
8 analysts

Consensus estimates, not results. Via Financial Modeling Prep.

Company Profile

CEO
David Dean Halbert
Sector
Healthcare
Industry
Biotechnology
Employees
1,846
Beta
0.70
Country
US
Piotroski score
4 / 9 (Middling)
Altman Z-score
4.15
www.carislifesciences.com